Loading stock data…
Loading stock data…
US$27.17
Get one email when MAZE crosses your level. Checked every 15 minutes during market hours.
▼ -2.23 (-7.57%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
43.7
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.89
Bearish momentumMACD below its signal line (1.20).
50-day average
26.75
Price aboveShort-term trend reference.
200-day average
34.52
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Maze Therapeutics Inc. is a clinical-stage biopharmaceutical company developing small molecule precision medicines for renal, cardiovascular, related metabolic diseases, and obesity. The company harnesses human genetics through its Compass platform to identify genetic variants in diseases and link them to biological pathways driving conditions in specific patient populations, a process called variant functionalization. Its lead program, MZE829, is an oral small molecule inhibitor of apolipoprote…
www.mazetx.com7 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (18 analysts, 2026-07-01)
5 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (12 analysts, 2026-06-01)
5 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (12 analysts, 2026-05-01)
5 strong buy · 6 buy · 1 hold · 0 sell · 0 strong sell (12 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-03-25 | -0.69 | -0.65 | ✓ Beat |
| 2025-11-06 | -0.69 | -0.66 | ✓ Beat |
| 2025-10-15 | 1.34 | 1.37 | ✓ Beat |
| 2025-08-12 | -1.15 | -0.77 | ✓ Beat |
| 2025-05-14 | -0.63 | -1.15 | ✗ Miss |
| 2025-03-31 | 0.45 | -18.32 | ✗ Miss |
Companies in the same industry, via Finnhub